A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

Completed · Phase 2

Conditions studied: Asthma

In brief

The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.

Key facts

Study ID

NCT00116103

Run by

Astellas Pharma Inc

Starts

2005-06-01

Expected to finish

2006-04-01

Last updated by the study team

2012-06-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of persistent asthma for at least 6 months
• Require use of beta-agonists at least four times per week

You may not qualify if…

• Diagnosis of chronic obstructive pulmonary disease (COPD)

Where it is running

• Study site — Scottsdale, Arizona, United States
• Study site — Encinitas, California, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — San Jose, California, United States
• Study site — Denver, Colorado, United States
• Study site — Daytona Beach, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Boise, Idaho, United States
• Study site — River Forest, Illinois, United States
• Study site — South Bend, Indiana, United States
• Study site — St Louis, Missouri, United States
• Study site — Missoula, Montana, United States
• Study site — Omaha, Nebraska, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Providence, Rhode Island, United States
• Study site — Spartanburg, South Carolina, United States
• Study site — San Antonio, Texas, United States
• Study site — Madison, Wisconsin, United States
• Study site — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.